Evaluation of cellular antioxidant and antiproliferative activities of five main Phyllanthus emblica L
Zibotentan is an antagonist targeting the ETA receptor and is currently undergoing Phase 2 clinical development for the treatment of portal hypertension, cirrhosis, albuminuria, type 2 diabetes, chronic kidney disease, liver disease, and more
If your main complaint is light, non-restorative sleep regardless of duration, DSIP promotion of delta-wave sleep targets that specific deficit
This GATA1-driven transcriptional program ensures the generation of mature red blood cells devoid of mitochondria
Comparison of treatments was done on a within-subject level (each mouse was its own control) and at least 1 week elapsed between each testing condition (drug or control treatment)
Antioxidants have many important roles in the body, the most important of which is to minimize cell damage caused by the aging process and free radicals in the body
